You can find the Program Book Here.
Please find below the list of selected abstract for the ILC Symposium 2024.
| Abstract ID | First name | Last Name | Institute or Affiliation: | Abstract Title: |
|---|---|---|---|---|
| ORAL | William | Yang | Institute of Cancer Research | E-cadherin/Aurora-A kinase inhibitor synthetic lethality highlights novel therapeutic vulnerabilities for targeting metastatic lobular breast cancer. |
| ORAL | Eduardo | Pena | King’s College London | Insights into the Transcriptomic and Immune Heterogeneity of Pleomorphic Invasive Lobular Breast Cancer |
| ORAL | Gitte | Zels | KU Leuven | Clinical and histopathological characterisation of metastatic invasive lobular breast cancer: lessons learned from post-mortem tissue donation programs |
| ORAL | Sana | Shabbir | University of Edinburgh | Role of Interleukin-6 in regulating estrogen signaling and endocrine therapy resistance in Invasive Lobular Carcinoma |
| ORAL | Insa | Thale | University of Pittsburgh | Characterization of a Syngeneic ER+ Mouse Model Representing Invasive Lobular Breast Carcinoma |
| ORAL | Abdalla | Wedn | Women’s Cancer Research Center, Magee Women’s Research Institute, UPMC Hillman Cancer Center, Pittsburgh, PA, USA | Hypomethylation and over-expression of AP2b in ILC causes increased growth due to effects on cell cycle |
| POSTER-01 | Guilherme | Nader Marta | Dana-Farber Cancer Institute | Subtype-specific prognostic value of lobular histology in patients with early-stage breast cancer: a nationwide population-based study |
| POSTER-02 | Lounes | Djerroudi | Institut Curie | Clinico-pathological Characteristics of Breast Invasive Lobular Carcinoma in non-CDH1 genetic predisposition. Experience from the Institut Curie. |
| POSTER-03 | Matteo | Serra | Institut Jules Bordet | Spatial Transcriptomics-Derived Classification of Invasive Lobular Carcinoma: Associations with Clinical, Genomic Characteristics, and Prognosis |
| POSTER-04 | Azime | AKÇAÖZ-ALASAR | Izmir Institute of Technology | ANALYSIS OF m6A RNA MODIFICATION PATTERNS IN INVASIVE LOBULAR BREAST CANCER |
| POSTER-05 | Aeree | Kim | Korea University Guro Hospital | Comprehensive characterization of invasive mammary carcinoma with lobular features: Integrating morphology and E-cadherin immunochemistry pattern |
| POSTER-06 | Karen | Van Baelen | KU Leuven | Clinical challenges and proposed solutions for invasive lobular breast cancer |
| POSTER-07 | Azadeh | Nasrazadani | MD Anderson Cancer Center | Invasive lobular carcinoma is rarely seen in inflammatory breast cancer and confers an inferior prognosis. |
| POSTER-08 | Esme | Bullock | University of Edinburgh | Cancer-associated fibroblast driven paracrine IL-6/STAT3 signalling promotes migration and dissemination of Invasive Lobular Carcinoma cells. |
| POSTER-09 | Naomi | Eastwood | University of Manchester | Deciphering the Transcription Factor Network and Enhancer Activity Controlled by ARID1A in Lobular Cancers |
| POSTER-10 | Jagmohan | Hooda | University of Pittsburgh | Establishing a Comprehensive Living Biobank of ILC Patient-Derived Organoids to Advance Breast Cancer Research |
| POSTER-11 | Morgan | Cody | University of Pittsburgh School of Medicine | Is there mis and/or late diagnosis of metastatic ILC? A quantitative and qualitative analysis |
| POSTER-12 | Sumayya | Abdul Qadir | University of Toronto | Developing and Characterizing Models for Recurrent Invasive Lobular Breast Carcinoma with Nf1 and HER2/Neu Mutations |
| POSTER-13 | Laura | Kennedy | Vanderbilt University Medical Center | Targeted Neoadjuvant Treatment Trial for HER2-mutated Lobular Breast Cancer (Trial in Progress) |
| POSTER-14 | Chinasa A | Ufondu | Department of Pharmacology, Molecular Pharmacology and Therapeutics (MPaT), University of Minnesota, Twin Cities. | Unique interactions between E-cadherin loss and Estrogen receptor drive tumorigenesis in Invasive Lobular Cancer. |
| POSTER-15 | Jie Bin | Liu | University of Pittsburgh | Destabilizing HER2 with Neratinib or Ganetespib Enhances Preclinical Efficacy of Trastuzumab Deruxtecan in HER2-mutant Invasive Lobular Breast Cancer |
| POSTER-16 | Anne | Vincent-Salomon | Institut Curie | Breast cancer subtypes: a patient’s survey with a special focus on lobular breast cancer |
| POSTER-17 | Laurie | Hutcheson | Lobular Breast Cancer Alliance Inc. | Worldwide Collaboration Among Invasive Lobular Carcinoma Researchers and Patient Advocates Produces October 15th Global Lobular Breast Cancer Awareness Day |
| POSTER-18 | Claire | Turner | Lobular Breast Cancer UK | Changing UK Breast Cancer Treatment Guidelines Authors: Helen Coulthard1, Sara MacLennan2, Claire Turner3, 1. De Montfort University & Lobular Breast |
| POSTER-19 | Helen | Coulthard | De Montfort University | The co-creation of digital postcards to support those with an Invasive Lobular Carcinoma diagnosis |